Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2026-07-02 19:06:41 ET · period of report 2026-06-30 · accession 0001193125-26-295112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-02 19:06 | 2026-06-30 | NKTR | Zalevsky Jonathan | Chief R, D Off | S - Sale | $70.00 | -5,681 | 9,756 | -37% | -$397.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | S | D | 5,681 | $70.00 | 9,756 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. |